Breethe Abiomed Recovery RegisTry (BART)

NCT05473130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-09-04

No results posted yet for this study

Summary

The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.

Conditions

Interventions

DEVICE

Breethe Oxy-1 System

To pump, oxygenate, and remove carbon dioxide from blood during cardiopulmonary bypass with Breethe Oxy-1 System

Sponsors & Collaborators

  • Abiomed Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2024-04-02
Completion
2024-04-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05473130 on ClinicalTrials.gov